Recipient
Genecis Bioindustries Inc.Department
National Research Council CanadaAmount
$500.0K
Province
ONType
Contribution
Agreement Number
172-2022-2023-Q4-1002766
Purpose
As part of the international consortium project “Eurostars 2521 NextPHAse”, this project will focus on producing and utilizing novel PHA (polyhydroxyalkanoate) building blocks from organic waste streams, to develop novel bioplastic resin formulations and high value applications. These formulations will replicate the properties of commonly used petroleum plastics and will be drop-in solutions for existing plastic manufacturing facilities. Manufacturing high value applications from waste derived PHA biopolymers will contribute to a circular and bio-based economy.
Genecis Bioindustries Inc. × National Research Council Canada
15 grants totalling $2.1M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |